LANCASTER, PA & NORTHBROOK, IL-June 26, 2017-Continuum Clinical and Skipta announced the launch of the Center for Observational Research, connecting physicians and available real-world research opportunities within a private and secure digital environment.
Skipta is a social network of online medical communities. Continuum Clinical is recognized for the design and implementation of observational studies and registries. Together, the two companies are harnessing crowdsourcing for research sponsors seeking non-interventional study participants outside the usual academic/clinical trial investigative sites.
John Ciccio, President of Skipta states, “Skipta is thrilled to be working with Continuum Clinical, furthering our mission to support the professional, education and economic development of our members by bringing to them the latest study opportunities directly within their Skipta community. The Center for Observational Research adds another dimension to the type of content we offer members, and we know it’s content that they want. We recently conducted a survey among more than 700 primary care physicians, urologists, cardiologists, psychiatrists and pediatricians, and found that 80% of respondents were ‘extremely interested’ in receiving more information about observational studies.”
“Observational research generates vital clinical and economic evidence from real world medical practice, but first, research sponsors must identify and engage the physicians whose patients live with the diseases, and experience the treatments our clients wish to study,” said Jeff Trotter, president of Continuum Clinical. “With Skipta’s access to hundreds of thousands of verified healthcare professionals-already organized by medical specialty, and actively engaged on the web and on mobile devices-and our expertise in designing and implementing observational studies and registries, the Center for Observational Research marks the beginning of an exciting new era in this field.
Continuum will have exclusive access to Skipta’s verified members who have already expressed a strong interest in real world studies, thereby expediting the process of identifying and enrolling physicians and their patients into prospective observational research initiatives. The Center will serve as a direct and cost-effective response to operational challenges our clients have often expressed in accelerating the pace of observational studies and registries.”
The Center for Observational Research has initiated activity with observational study opportunities in a variety of therapeutic areas including immunology, oncology, dermatology and gastroenterology, and is available to accommodate new listings from research sponsors and CROs.
About Skipta
Skipta is a social network of online medical communities for verified healthcare professionals. Skipta’s growing network of more than 30 online medical communities enables healthcare professionals to communicate, consult, and exchange information within private and secure platforms per physician specialty, healthcare profession, or disease state. Skipta supports the medical advancement of its members by offering a range of collaborative peer based services that aid quality of care and contribute to improved patient outcomes. Skipta’s network provides trusted forums and a range of tools for the life sciences industry to engage with healthcare professionals. For more information, please visit skipta.com.
About Continuum Clinical
Continuum Clinical is a global healthcare research and communications company. With over thirty years of experience, Continuum Clinical brings together a blend of world-class experience in key disciplines, including strategic patient outreach communications, observational research and registries, study site optimization, advocacy relations, and health economics and outcomes research. Continuum Clinical provides a blend of resources and perspectives, proven expertise, and innovative solutions throughout the entire continuum of a product’s lifecycle-from pre-launch into the real world. Headquartered in the US, Continuum Clinical has staff in Europe and an expanded worldwide network of resources. For more information, please visit continuumclinical.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.